Ralph (Adam) Smith, Phd, Mba

Ralph (Adam) Smith, Phd, Mba Email and Phone Number

Scientific Senior Director - Imaging @ Bristol Myers Squibb
new jersey, united states
Ralph (Adam) Smith, Phd, Mba's Location
Greater Philadelphia, United States
About Ralph (Adam) Smith, Phd, Mba

Driven leader of translational imaging science dedicated to achieving productive collaborations that result in exceptional outcomes for patients. • Lead company-wide translational strategy for molecular imaging portfolio in all therapeutic areas • Responsible for clinical imaging (all modalities) for company lung fibrosis and early neuroscience portfolios – experience in clinical drug development, protocol writing/development, and regulatory submissions• Proven record of translating scientific discovery to clinical application – successful regulatory filings in US, Canada, and EU• Experience in integrating translational science / translational medicine approaches in drug development• Integrate and lead cross-functional scientific and research teams consisting of physicians, biologists, chemists, engineers, manufacturing, operational and regulatory components• Work recognized with 2017 Ondetti & Cushman Award (highest R&D award at Bristol-Myers Squibb) and 2014 Research Leveraging Technology Innovation Award• Adept at stakeholder and collaboration management linking industry, academia, andcommercial partners

Ralph (Adam) Smith, Phd, Mba's Current Company Details
Bristol Myers Squibb

Bristol Myers Squibb

View
Scientific Senior Director - Imaging
new jersey, united states
Website:
bms.com
Employees:
32449
Ralph (Adam) Smith, Phd, Mba Work Experience Details
  • Bristol Myers Squibb
    Scientific Senior Director - Imaging (Clinical Neuroscience, Lung Fibrosis, And Molecular Imaging)
    Bristol Myers Squibb Nov 2023 - Present
    Princeton, Nj
    Drive company-wide clinical imaging strategy and execution for Neuroscience and lung fibrosis clinical trials to enable decision-making for portfolio assets. Responsibilities include oversight of end-to-end novel tracer development, imaging integration with translational sciences and asset development plans in both discovery and early clinical phases, implementation and delivery of imaging endpoints in clinical trials, and establishment/maintenance of relationships with imaging core labs, CROs and KOLs. Integrate and coordinate contributions from multiple functional areas including biomarkers, discovery biology, chemistry, clinical, regulatory, and upper management to enable imaging applications across the development continuum.
  • Bristol-Myers Squibb
    Scientific Director - Imaging (Molecular Imaging, Clinical Lung Fibrosis And Early Neuro Lead)
    Bristol-Myers Squibb Mar 2018 - Oct 2023
    Princeton, Nj
  • Bristol-Myers Squibb
    Associate Director - Molecular Imaging Lead
    Bristol-Myers Squibb Oct 2015 - Mar 2018
    Princeton, Nj
    Lead company-wide molecular imaging portfolio for all therapeutic areas including preclinical, early development, and translation of novel imaging agents to the clinic. Responsible for designing and implementing molecular imaging strategy and novel tracer development to drive both preclinical and clinical asset development. Integrate and coordinate contributions from multiple functional areas to enable imaging tracer implementation to address key scientific questions from discovery through human trials. Received 2017 Ondetti & Cushman Award (highest scientific award at BMS) for implementation of novel imaging technologies to immuno-oncology platform.
  • Bristol-Myers Squibb
    Associate Director - Oncology Molecular Imaging Lead
    Bristol-Myers Squibb Aug 2014 - Oct 2015
    Princeton, Nj
    Lead molecular imaging for oncology and immuno-oncology portfolio including preclinical, early discovery, and late phase imaging. Responsible for designing and implementing molecular imaging strategy and novel tracer development to drive both preclinical and clinical asset development. Integrate and coordinate contributions from multiple functional areas to guide imaging tracer development from preclinical assessment to utilization in human trials.
  • Bristol-Myers Squibb, Princeton, New Jersey
    Senior Research Investigator Ii, Dmcp - Bioimaging
    Bristol-Myers Squibb, Princeton, New Jersey Jan 2012 - Aug 2014
    Princeton, Nj
    Project leader for preclinical PET and optical imaging serving multiple therapeutic areas. Responsible for design and implementation of imaging studies to impact preclinical and clinical development as well as clinical trial design. Interface with working groups and stakeholders to impact biomarker strategy for developing and marketed assets. Received 2014 Research Leveraging Technology Innovation award for implementation of novel imaging technologies to immuno-oncology platform.
  • Vanderbilt University Medical Center
    Research Fellow In Radiology
    Vanderbilt University Medical Center Nov 2009 - Nov 2011
    Manage collaborative preclinical imaging efforts for research group in an imaging core facility. Utilize imaging methodologies including nuclear ([18F]-FDG, [18F]-FLT, novel probes), CT, MRI, ultrasound, optical, as well as in vitro and ex vivo techniques (e.g. MALDI-IMS, IHC, confocal microscopy). Imaging of tumor models including glioma, colorectal, and breast. Extensive use of quantitative analysis applied to PET imaging data, including compartmental modeling to determine tracer kinetic parameters. Designed and implemented regimen for collection and co-registration of 3-D imaging data sets including PET, CT, MRI, MALDI-IMS, and histology for robust quantitative voxel-by-voxel correlation of measured imaging metrics, anatomical structures, and biological parameters.
  • Massachusetts General Hospital/Harvard Medical School
    Research Fellow
    Massachusetts General Hospital/Harvard Medical School Mar 2006 - Oct 2009
    Part of interdisciplinary and highly collaborative team consisting of chemists/medicinal chemists, biologists, engineers, and physicians developing and assessing novel compounds for the treatment and imaging of cancer and inflammation. Focus on pharmacological effects, biodistribution, and intracellular distribution of viridin analogs and antibody-based compounds in both cellular in vitro assays and murine tumor models. Work includes extensive use of in vitro and in vivo cell and tumor proliferation and biodistribution assays, ex vivo analysis of murine tissues, FACS analysis, fluorescence and intravital microscopy, western blotting, and various biological techniques.

Ralph (Adam) Smith, Phd, Mba Education Details

Frequently Asked Questions about Ralph (Adam) Smith, Phd, Mba

What company does Ralph (Adam) Smith, Phd, Mba work for?

Ralph (Adam) Smith, Phd, Mba works for Bristol Myers Squibb

What is Ralph (Adam) Smith, Phd, Mba's role at the current company?

Ralph (Adam) Smith, Phd, Mba's current role is Scientific Senior Director - Imaging.

What schools did Ralph (Adam) Smith, Phd, Mba attend?

Ralph (Adam) Smith, Phd, Mba attended Drexel University's Lebow College Of Business, Vanderbilt University, The Johns Hopkins University.

Who are Ralph (Adam) Smith, Phd, Mba's colleagues?

Ralph (Adam) Smith, Phd, Mba's colleagues are Patrick Vincenten, Kelsy Tinsley, Denise Bennett, Akiko Amakawa, Lorraine Burianek, Jannicia Bullock, Danielle Goodheart.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.